Patients on long-term non-steroidal anti-inflammatory drugs (NSAID) were seen to have a reduced risk of developing Alzheimer's disease, but the mechanisms underlying this observation remain unclear.
Observational studies have previously reported a higher risk for venous thromboembolism (VTE) in people who use nonsteroidal anti-inflammatory drugs (NSAIDs) than in those who don’t use NSAIDs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results